ID: h-869b5707e8
Hypothesis
TREM2 Microglial Agonism for Enhanced Phagocytosis
TREM2 agonism enhances microglial phagocytosis of α-synuclein aggregates via DAP12 signaling.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
TREM2 agonism enhances microglial phagocytosis of α-synuclein aggregates via DAP12 signaling. Alector AL002 anti-TREM2 antibody in Phase II represents clinical validation, but temporal dynamics, species divergence, and biomarker gaps remain critical challenges for translation.
🧬 Mechanism
No curated mechanism pathway recorded for this hypothesis.
⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Supports
TREM2 R47H variant associates with increased AD risk; PD association weaker but present
Contradicts
Conditional TREM2 knockout in some models shows preserved aggregate clearance
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — TREM2
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TREM2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.8%
Volatility
Low
0.0012
Events (7d)
3
Price History
▼5.5%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
Parent Context
▸Metadataorigin_type: debate_synthesizer
| origin_type | debate_synthesizer |
| target_gene | TREM2 |
| _schema_version | 1 |
| composite_score | 0.59 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.